[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  John Zidar [@JohnZidar](/creator/twitter/JohnZidar) on x 5889 followers Created: 2025-07-18 01:54:50 UTC $MESO - Mesoblast 🔹Reported strong initial results from the commercial launch of Ryoncil® 🔹Generated $13.2M revenue from Ryoncil® in first quarter post-launch 🔹Strong market position with 7-year orphan drug exclusivity and biologic exclusivity through 2036 🔹Robust cash position of $162M as of June 30, 2025 🔹Successfully onboarded 25+ transplant centers, targeting XX% of US pediatric transplants 👆 XX% / $XXXXX  XXX engagements  **Related Topics** [$162m](/topic/$162m) [$132m](/topic/$132m) [generated](/topic/generated) [$meso](/topic/$meso) [Post Link](https://x.com/JohnZidar/status/1946025842456350755)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
John Zidar @JohnZidar on x 5889 followers
Created: 2025-07-18 01:54:50 UTC
$MESO - Mesoblast 🔹Reported strong initial results from the commercial launch of Ryoncil® 🔹Generated $13.2M revenue from Ryoncil® in first quarter post-launch 🔹Strong market position with 7-year orphan drug exclusivity and biologic exclusivity through 2036 🔹Robust cash position of $162M as of June 30, 2025 🔹Successfully onboarded 25+ transplant centers, targeting XX% of US pediatric transplants
👆 XX% / $XXXXX
XXX engagements
/post/tweet::1946025842456350755